Poor in vitro activity of ceftazidime/avibactam against carbapenem-resistant Escherichia coli and Klebsiella pneumoniae in India: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2018 - 2021

Int J Antimicrob Agents. 2024 Mar;63(3):107087. doi: 10.1016/j.ijantimicag.2024.107087. Epub 2024 Jan 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Azabicyclo Compounds*
  • Carbapenem-Resistant Enterobacteriaceae*
  • Carbapenems / pharmacology
  • Ceftazidime* / pharmacology
  • Escherichia coli
  • Klebsiella pneumoniae
  • Leadership

Substances

  • Ceftazidime
  • avibactam
  • Anti-Bacterial Agents
  • Carbapenems
  • Azabicyclo Compounds